H. Schlitt

发表

b of Glycogen Synthase Kinase-3 Intestinal Inflammation via Phosphorylation IL-13 Orchestrates Resolution of Chronic

F. Obermeier, E. Geissler, M. Haimerl, 2014 .

Covid19 vaccination-associated portal vein thrombosis—An interdisciplinary clinical challenge

S. Heimerl, C. Eissnert, A. Doenecke, 2022, Clinics and Research in Hepatology and Gastroenterology.

Human herpesvirus-6 and liver transplantation.

H. Schlitt, Liwei Shi, 2002, Journal of hepatology.

Isolation, Culture, and Characterization of Human Pancreatic Duct Cells

E. Hahn, B. Trautmann, H. Schlitt, 1993, Pancreas.

Banff schema for grading liver allograft rejection: An international consensus document

Randall G. Lee, K. Batts, R. Wiesner, 1997, Hepatology.

Influence of arginine, omega-3 fatty acids and nucleotide-supplemented enteral support on systemic inflammatory response syndrome and multiple organ failure in patients after severe trauma.

G. Regel, M. Grotz, G. Tusch, 1998, Nutrition.

Hepatic progenitor cells from adult human livers for cell transplantation

W. Thasler, T. Weiss, B. Christ, 2008, Gut.

High volume naked DNA tail‐vein injection restores liver function in Fah‐knock out mice

E. Geissler, P. Piso, E. Eggenhofer, 2010, Journal of gastroenterology and hepatology.

Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma.

C. Hellerbrand, W. Thasler, T. Schlott, 2005, Histopathology.

Interactions of allogeneic human mononuclear cells in the two‐way mixed leucocyte culture (MLC): influence of cell numbers, subpopulations and cyclosporin

A. Deiwick, K. Koyama, T. Sato, 1999, Clinical and experimental immunology.

Living Donor Liver Transplantation From Hepatitis C–Infected Donor to Hepatitis C–Infected Recipient

M. Melter, F. Brennfleck, S. Brunner, 2020, Hepatology.

Subclinical T cell-mediated liver transplant rejection: The jury is still out.

J. Hutchinson, H. Schlitt, 2018, Journal of Hepatology.

Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma

C. Hellerbrand, T. Schlott, F. Bataille, 2005 .

Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion

E. Geissler, E. Eggenhofer, V. Benseler, 2012, Front. Immun..

Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate.

E. Geissler, P. Piso, E. Eggenhofer, 2008, Transplant immunology.

VEGF: a surrogate marker for peripheral vascular disease.

E. Geissler, H. Schlitt, P. Kasprzak, 2010, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.